“Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer” (2019) Biomolecules and Biomedicine, 19(3), pp. 227–233. doi:10.17305/bjbms.2019.4204.